Your browser doesn't support javascript.
loading
Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy.
Butner, Joseph D; Farhat, Maguy; Cristini, Vittorio; Chung, Caroline; Wang, Zhihui.
Afiliación
  • Butner JD; Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA. Electronic address: jbutner@houstonmethodist.org.
  • Farhat M; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Cristini V; Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA; Neal Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA; Department of Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA; Physiology, Biophysic
  • Chung C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: cchung3@mdanderson.org.
  • Wang Z; Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA; Neal Cancer Center, Houston Methodist Research Institute, Houston, TX 77030, USA; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medical Education,
STAR Protoc ; 3(4): 101886, 2022 12 16.
Article en En | MEDLINE | ID: mdl-36595890
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Inmunoterapia Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: STAR Protoc Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Puntos de Control Inmunológico / Inmunoterapia Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: STAR Protoc Año: 2022 Tipo del documento: Article